TNFSF10 and neoplasm: These fusogenic lipoplexes (FLPPs) effectively avoid lysosomal trapping and have also been modified by PEG and tumor homing peptide (CRGDK), thereby enhancing stable circulation, tumor accumulation and therapeutic efficacy by using the TRAIL gene.